TP53 and breast carcinoma: In addition, we offer TP53 sequencing for women with breast cancer diagnosed at the age of 30 or below, as it was reported that about 5% of these women carry a TP53 mutation, and radiotherapy is contraindicated for TP53 mutation positive cases [59].